Headache response to glyceryl trinitrate in patients with and without obstructive coronary artery disease

Heart

Volumn 91, Issue 9, 2005, Pages 1164-1166

  Hsi, David H ^a,b   Roshandel, A ^c   Singh, N ^b   Szombathy, T ^d   Meszaros, Z S ^d  

^a Park Ridge Hospital ^*  (United States)

^b UNITY HEALTH SYSTEM   (United States)

^c PROVIDENCE HOSPITAL   (United States)

^d ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHEST PAIN SYNDROME; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THORAX PAIN;

AGED; CHEST PAIN; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; VASODILATOR AGENTS;

EID: 23944467997     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.035295     Document Type: Article

References (22)

1. Murrell W. Nitroglycerine as a remedy for angina pectoris. Lancet. 1879;i: 80-1, 113).
2. Darius H. Role of nitrates for the therapy of coronary artery disease patients in the years beyond 2000. J Cardiovasc Pharmacol 1999;34:S15-20.
3. Parker JD, Parker JO. Nitrate therapy for stable angina pectoris. N Engl J Med 1998;338:520-31.
4. Tattersall AB, Bridgman KM, Carr M. Retrospective post-marketing surveillance of Transderm-Nitro in general practices in the United Kingdom. J Int Med Res 1985;13:222-8.
5. Brown BG, Bolson E, Petersen RB, et al. The mechanism of nitroglycerin action: stenosis vasodilatation as a major component of drug response. Circulation 1981;64:1089-97.
6. Goldstein RE, Stinson EB, Scherer JL, et al. Infra-operative coronary collateral function in patients with coronary occlusive disease: nitroglycerin responsiveness and angiographic correlation. Circulation 1974;49:298-308.
7. Lai CP, Koyanagi S, Shaw CK, et al. Evaluation of the early stage of carotid atherosclerosis using the vascular response to nitroglycerin and nigh-resolution ultrasonography. Jpn Circ J 1998;7:494-8.
8. Adams MR, Robinson J, Mccredie R, et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998;32:123-7.
9. Lundman P, Eriksson M, Schenck-Gustafsson K, et al. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary artery diseases. Circulation 1997;96:3266-8.
10. Raitakari OT, Seale JP, Celermajer DS. Impaired vascular response to nitroglycerin in subjects with coronary atherosclerosis. Am J Cardiol 2001;87:217-9.
11. Senior R, Soman P, Khattar RS, et al. Prognostic value of dobutamine stress echocardiography in patients undergoing diagnostic coronary arteriography. Am J Cardiol 1997;79:1610-4.
12. Rallidis L, Cokkinos P, Tousouli D, et al. Comparison of dobutamine and treadmill exercise echocardiography in inducing ischemia in patients with coronary artery disease. J Am Coll Cardiol 1997;30:1660-8.
13. Berman DS, Kiat HS, Van Train KF, et al. Myocardial perfusion imaging with technetium-99m-sestamibi: comparative analysis of available imaging protocols. J Nucl Med 1994;35:681-8.
14. Taillefer R, DePuey EG, Udelson JE, et al. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997;29:69-77.
15. Shavelle DM, Budoff MJ, LaMont DH, et al. Exercise testing electron beam computed tomography in the evaluation of coronary artery disease. J Am Coll Cardiol 2000;36:32-8.
16. Smart SC, Bhatia A, Hallman R, et al. Dobutamine-atropine stress echocardiography and dipyridamole sestamibi scintigraphy for the detection of coronary artery disease: limitations and concordance. J Am Coll Cardiol 2000;36:1265-73.
17. Livschitz S, Sharabi Y, Yushin J, et al. Limited clinical value of exercise stress test for the screening of coronary artery disease in young, asymptomatic men. Am J Cardiol 2000;86:462-4.
18. Geleijnse ML, Elhendy A, van Domburg RT, et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain, echocardiography, perfusion scintigraphy, or both? Circulation 1997;96:137-47.
19. Hlatky MA, Pryor DB, Harrell FE, et al. Factors affecting sensitivity and specificity of exercise electrocardiography: a multi-variable analysis. Am J Med 1984;14:1440-7.
20. Cortigiani L, Dodi C, Paolini EA, et al. Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease. J Am Coll Cardiol 1998;32:1975-81.
21. Kwok Y, Kim K, Grady D, et al. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660-6.
22. Ho KT, Miller TD, Hodge DO, et al. Use of a simple clinical score to predict prognosis of patients with normal or mildly abnormal resting electrocardiographic findings undergoing evaluation for coronary artery disease. Mayo Clin Proc 2002;77:515-21.